{"id":"https://openalex.org/W7225198625","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0822","title":"822 CYT X300, a novel EGFR x pan-gamma delta T cell engager for the treatment of solid tumors","display_name":"822 CYT X300, a novel EGFR x pan-gamma delta T cell engager for the treatment of solid tumors","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225198625","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0822"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0822","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0822","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0822","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A934.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_2/A934.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001792404","display_name":"James William Legg","orcid":"https://orcid.org/0009-0009-6450-7971","observed_orcids":["https://orcid.org/0009-0009-6450-7971"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James W Legg","raw_affiliation_strings":["Cytospire Therapeutics, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cytospire Therapeutics, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037328142","display_name":"Mark Uden","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Uden","raw_affiliation_strings":["Cytospire Therapeutics, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cytospire Therapeutics, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160513825","display_name":"Robert Good","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Good","raw_affiliation_strings":["Cytospire Therapeutics, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cytospire Therapeutics, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5095089877","display_name":"Julie Julie Hoong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julie Hoong","raw_affiliation_strings":["Cytospire Therapeutics, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cytospire Therapeutics, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160569038","display_name":"Aleksandra Laskowska","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aleksandra Laskowska","raw_affiliation_strings":["Cytospire Therapeutics, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cytospire Therapeutics, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004278572","display_name":"Fevzi Demircioglu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fevzi Demircioglu","raw_affiliation_strings":["Cytospire Therapeutics, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cytospire Therapeutics, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042864386","display_name":"Roseanna K. Hare","orcid":"https://orcid.org/0000-0001-8974-2489","observed_orcids":["https://orcid.org/0000-0001-8974-2489"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roseanna Hare","raw_affiliation_strings":["Cytospire Therapeutics, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cytospire Therapeutics, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5133857646","display_name":"Shauna Corcoran","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shauna Corcoran","raw_affiliation_strings":["Cytospire Therapeutics, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cytospire Therapeutics, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019213453","display_name":"Valentina Cazzetta","orcid":"https://orcid.org/0000-0001-7183-2793","observed_orcids":["https://orcid.org/0000-0001-7183-2793"]},"institutions":[{"id":"https://openalex.org/I4210163047","display_name":"IRCCS Humanitas Research Hospital","ror":"https://ror.org/05d538656","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210163047"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Valentina Cazzetta","raw_affiliation_strings":["Humanitas Research Hospital, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Humanitas Research Hospital, Milan, Italy","institution_ids":["https://openalex.org/I4210163047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024357529","display_name":"Joanna Mikulak","orcid":"https://orcid.org/0000-0001-8310-9543","observed_orcids":["https://orcid.org/0000-0001-8310-9543"]},"institutions":[{"id":"https://openalex.org/I4210163047","display_name":"IRCCS Humanitas Research Hospital","ror":"https://ror.org/05d538656","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210163047"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Joanna Mikulak","raw_affiliation_strings":["Humanitas Research Hospital, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Humanitas Research Hospital, Milan, Italy","institution_ids":["https://openalex.org/I4210163047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069740647","display_name":"Luke Cave","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luke Cave","raw_affiliation_strings":["Cytospire Therapeutics, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cytospire Therapeutics, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006356929","display_name":"Carlotta Cattolico","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carlotta Cattolico","raw_affiliation_strings":["Cytospire Therapeutics, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cytospire Therapeutics, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5133828658","display_name":"Leia Griffin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leia Griffin","raw_affiliation_strings":["Cytospire Therapeutics, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cytospire Therapeutics, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021041745","display_name":"Domenico Mavilio","orcid":"https://orcid.org/0000-0001-6147-0952","observed_orcids":["https://orcid.org/0000-0001-6147-0952"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I4210163047","display_name":"IRCCS Humanitas Research Hospital","ror":"https://ror.org/05d538656","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210163047"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Domenico Mavilio","raw_affiliation_strings":["Humanitas Research Hospital, Milan, Italy","University of Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Humanitas Research Hospital, Milan, Italy","institution_ids":["https://openalex.org/I4210163047"]},{"raw_affiliation_string":"University of Milan, Milan, Italy","institution_ids":["https://openalex.org/I189158943"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040145591","display_name":"Natalie M. Mount","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Natalie Mount","raw_affiliation_strings":["Cytospire Therapeutics, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cytospire Therapeutics, London, UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A934","last_page":"A934"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.28929999470710754,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.28929999470710754,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.26759999990463257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.19599999487400055,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gamma-delta-t-cells","display_name":"\u03b3\u03b4 T cells","score":0.8510000109672546},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.871999979019165},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.7310000061988831},{"id":"https://openalex.org/keywords/tumor-associated-antigens","display_name":"tumor-associated antigens","score":0.777999997138977},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.8880000114440918},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8650000095367432},{"id":"https://openalex.org/keywords/non-human-primate-toxicity","display_name":"non-human primate toxicity","score":0.5899999737739563},{"id":"https://openalex.org/keywords/anti-egfr-monoclonal-antibody","display_name":"anti-EGFR monoclonal antibody","score":0.5730000138282776},{"id":"https://openalex.org/keywords/tumor-cell-killing","display_name":"tumor cell killing","score":0.4259999990463257},{"id":"https://openalex.org/keywords/adoptive-t-cell-therapy","display_name":"adoptive T cell therapy","score":0.5770000219345093},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.5249999761581421}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6111000180244446},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5917999744415283},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5601000189781189},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4456999897956848},{"id":"https://openalex.org/C2993640289","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Solid tumor","level":3,"score":0.38449999690055847},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.38269999623298645},{"id":"https://openalex.org/C5072461","wikidata":"https://www.wikidata.org/wiki/Q49506","display_name":"Delta","level":2,"score":0.3179999887943268},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.24289999902248383},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23980000615119934},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.22100000083446503}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.0822","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0822","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0822","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A934.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:063d55c2de48437dabe70b3eabc60e5a","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/063d55c2de48437dabe70b3eabc60e5a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 14, Iss Suppl 2 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0822","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0822","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0822","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A934.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225198625.pdf","grobid_xml":"https://content.openalex.org/works/W7225198625.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7154700363","https://openalex.org/W7225195518","https://openalex.org/W7225194716","https://openalex.org/W2430636310","https://openalex.org/W7225175517","https://openalex.org/W2561285453","https://openalex.org/W3083279071","https://openalex.org/W4312463763","https://openalex.org/W1969511223","https://openalex.org/W7148802188"],"abstract_inverted_index":{"Background":[0],"CD3":[1,349],"T":[2,79],"cell":[3,293,395],"engagers":[4],"(TCEs)":[5],"are":[6,81,120,158],"an":[7,211],"emerging":[8],"immunotherapeutic":[9],"modality,":[10],"however,":[11],"their":[12,247,422],"application":[13],"in":[14,152,259,278,324,406],"solid":[15,156,201,386],"tumors":[16,157,387],"has":[17,274],"so":[18],"far":[19],"been":[20,343],"limited":[21],"by":[22,51,160,433,456],"a":[23,82,144,153,188,194,206,227,234,264,344,379,382],"paucity":[24],"of":[25,55,60,73,85,91,155,185,242,254,266,307,315,346,384,409,439],"truly":[26],"tumor":[27,110,161,219,298,402],"restricted":[28],"antigens":[29],"leading":[30],"to":[31,108,115,122,174,210,374],"unacceptable":[32],"toxicity":[33],"from":[34,111,291],"healthy":[35,112,310],"tissue":[36],"damage":[37],"and":[38,64,67,93,166,222,233,245,283,318,335,364,391,393,411,426,437,473],"cytokine":[39],"release":[40],"syndrome":[41],"(CRS).Methods":[42],"Cytospire\u2019s":[43],"approach":[44],"enables":[45],"TCE":[46,191],"development":[47],"using":[48],"well-validated":[49],"TAAs":[50],"engaging":[52],"specific":[53],"subsets":[54,241],"cytotoxic":[56],"immune":[57],"cells":[58,66,80,86,97,164,173,217,244,256,290,311],"capable":[59],"distinguishing":[61],"between":[62],"malignant":[63],"non-malignant":[65],"killing":[68,253,306],"whilst":[69],"producing":[70],"lower":[71],"levels":[72],"CRS-causing":[74],"cytokines.":[75],"Gamma":[76],"delta":[77],"(\u03b3\u03b4)":[78],"promising":[83],"class":[84],"acting":[87],"at":[88],"the":[89,260,338,407,434,461],"nexus":[90],"innate":[92],"adaptive":[94],"immunity.":[95],"\u03b3\u03b4T":[96,141,163,216,243,289],"drive":[98,321],"potent":[99,252],"anti-cancer":[100],"activity,":[101],"while":[102],"utilising":[103],"functionally":[104],"redundant":[105],"stress":[106],"markers":[107],"discriminate":[109],"cells.":[113,142],"Due":[114],"this":[116],"biology,":[117],"\u03b3\u03b4":[118,135,178],"TCEs":[119,136],"considered":[121],"have":[123,137,342],"great":[124],"potential":[125],"as":[126,171,378],"effectors":[127],"for":[128,381],"next":[129],"generation":[130],"TCEs.":[131],"To":[132],"date,":[133],"clinical-stage":[134],"leveraged":[138],"blood-resident":[139],"(V\u03b42)":[140],"However,":[143],"growing":[145],"literature":[146],"showing":[147],"that":[148,320,328,341],"favourable":[149],"patient":[150,297],"outcomes":[151],"range":[154,262,265,383],"driven":[159],"resident":[162,220],"(V\u03b41":[165],"V\u03b43":[167,223],"cells),":[168],"elevating":[169],"these":[170,353],"essential":[172],"leverage":[175],"with":[176,226,257,443],"novel":[177,189,207],"TCEs.Results":[179],"Here,":[180],"we":[181],"present":[182,213],"preclinical":[183,362],"characterisation":[184],"CYT":[186,203,237,249,272,301,329,355,376],"X300,":[187],"pan-\u03b3\u03b4":[190],"targeting":[192],"EGFR,":[193],"broadly":[195],"expressed,":[196],"clinically":[197,228],"validated":[198,229],"TAA":[199],"on":[200,214,352],"tumors.":[202],"X300":[204,238,250,273,302,330,356,377],"incorporates":[205],"antibody":[208,231],"binder":[209],"epitope":[212],"all":[215,240],"including":[218,388],"V\u03b41":[221],"cells,":[224],"coupled":[225],"anti-EGFR":[230],"domain":[232],"silenced":[235],"Fc.":[236],"activates":[239,287],"induces":[246],"proliferation.":[248],"drives":[251],"cancer":[255,281,295],"EC50s":[258],"picomolar":[261],"across":[263],"EGFR":[267,347],"expression":[268],"levels.":[269],"In":[270],"vivo,":[271],"robust":[275],"anti-tumor":[276],"activity":[277],"two":[279],"murine":[280],"models,":[282],"ex":[284,400],"vivo":[285,401],"potently":[286],"primary":[288],"non-small":[292,394],"lung":[294,396],"(NSCLC)":[296],"samples.":[299],"Crucially,":[300],"does":[303],"not":[304],"induce":[305,337],"primary,":[308],"EGFR-positive":[309,385],"nor":[312],"excessive":[313],"production":[314],"cytokines":[316],"(IL-6":[317],"TNF\u03b1)":[319],"CRS.":[322],"Studies":[323],"non-human":[325],"primates":[326],"demonstrate":[327],"is":[331,357,371],"very":[332],"well":[333],"tolerated":[334],"doesn\u2019y":[336],"severe":[339],"toxicities":[340],"hallmark":[345],"x":[348],"engagers.Conclusions":[350],"Based":[351],"data,":[354],"being":[358,372],"advanced":[359],"through":[360],"IND-enabling":[361],"studies":[363,448],"GMP":[365],"manufacturing.":[366],"A":[367],"first-in-human":[368],"clinical":[369],"study":[370],"planned":[373],"evaluate":[375],"treatment":[380],"colorectal,":[389],"head":[390],"neck":[392],"cancers.Ethics":[397],"Approval":[398],"NSCLC":[399],"experiments":[403],"were":[404,450,465],"performed":[405,451],"Laboratory":[408],"Clinical":[410],"Experimental":[412],"Immunology,":[413],"IRCCS":[414],"Humanitas":[415,440],"Research":[416,441],"Hospital,":[417],"Rozzano,":[418],"Milan,":[419],"Italy":[420],"under":[421,452],"local":[423],"ethics":[424,453],"approval":[425,444],"informed":[427],"consent.":[428],"The":[429],"protocol":[430],"was":[431],"approved":[432],"ethical":[435],"Committee":[436],"IRB":[438],"Hospital":[442],"number":[445],"3631.":[446],"Animal":[447],"described":[449],"approvals":[454],"obtained":[455],"our":[457],"CRO":[458],"partners":[459],"performing":[460],"work.":[462],"These":[463],"CROs":[464],"Crown":[466],"Bio":[467],"(China),":[468],"Charles":[469],"River":[470],"Labs":[471],"(Germany)":[472],"WuXi":[474],"Biologics":[475],"(China).":[476]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-11-04T00:00:00"}